Provided by Tiger Fintech (Singapore) Pte. Ltd.

BAIYUNSHAN PH

20.220
-0.040-0.20%
Volume:293.00K
Turnover:5.94M
Market Cap:32.88B
PE:10.59
High:20.400
Open:20.100
Low:20.100
Close:20.260
52wk High:20.400
52wk Low:15.014
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:1.10
T/O Rate:0.13%
Dividend:0.88
Dividend Rate:4.33%
EPS(LYR):1.910
ROE:7.97%
ROA:2.85%
PB:0.79
PE(LYR):10.59
PS:0.39

Loading ...

Hong Kong Stock Connect Holdings Analysis for October 15

Stock News
·
Oct 15

Baiyunshan Pharmaceutical Appoints Vice Chair

MT Newswires Live
·
Sep 29

Hong Kong Stock Early Insight | Eight Departments Issue Guidelines to Promote Non-Ferrous Metals Industry Stable Growth, Hong Kong to Build Global Fixed Income and Currency Products Hub

Stock News
·
Sep 29

Hong Kong Stock Announcements Highlights | MINISO Proposes Spinoff of TOP TOY for Independent Listing on Hong Kong Stock Exchange Main Board

Stock News
·
Sep 28

BAIYUNSHAN PH (00874): Chen Jiehui Appointed as Deputy Chairman

Stock News
·
Sep 28

Baiyunshan Pharmaceutical Registers Phase 2 Trial for Stomach Flu Traditional Chinese Drug

MT Newswires Live
·
Sep 23

Artini to Jointly Develop Big Healthcare Products With Guangzhou Baiyunshan Pharmaceutical Unit

MT Newswires Live
·
Sep 22

Heritage Continues, Family Values Endure! Baiyunshan Xiaochaihu's "Inherit Good Ancient Formulas, Inherit Good Family Values" 8th Anniversary Charity Event Grandly Opens in Yantai, Shandong

Deep News
·
Sep 22

ARTINI HLDG (00789) Signs Strategic Partnership Agreement with Baiyunshan Weiy for Joint R&D in Health Industry and Market Expansion

Stock News
·
Sep 19

BAIYUNSHAN PH (00874) Subsidiary Receives Drug Supplementary Application Approval Certificates

Stock News
·
Sep 16

Baiyunshan Pharmaceutical Gets Green Light to Proceed to Phase II of BYS10 Tablets Trial

MT Newswires Live
·
Sep 16

Guangzhou Baiyunshan (SEHK:874): Exploring Its Valuation After a Year of Steady Share Price Gains

Simply Wall St.
·
Sep 14

Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Ceftazidime for Injection Passes Generic Drug Consistency Evaluation

Stock News
·
Sep 03

Baiyunshan Pharma Gets Nod to Make Amendments to Two Antibiotics

MT Newswires Live
·
Sep 02

BAIYUNSHAN PH (00874): Subsidiary Baiyunshan Hanfang Receives Marketing Authorization for Structured Triglycerides Chemical Raw Material

Stock News
·
Aug 29

BAIYUNSHAN PH (00874): Guangzhou Pharmaceutical Sells Fourth Batch of Additional Basic Assets to Xingzheng Asset Management

Stock News
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Disposals of Accounts Receivable

THOMSON REUTERS
·
Aug 28

Guangzhou Baiyunshan Pharmaceutical - Confirm Disposal of Fourth New Underlying Assets of Gp Corp for RMB502 Mln

THOMSON REUTERS
·
Aug 28

BAIYUNSHAN PH (00874): Completes Private Fund Registration

Stock News
·
Aug 19

Traditional Medicine Sector Under Pressure as Baiyunshan Faces Performance Challenges

Deep News
·
Aug 19